Edition:
United States

Axovant Sciences Ltd (AXON.OQ)

AXON.OQ on NASDAQ Stock Exchange Global Select Market

1.01USD
18 Jan 2019
Change (% chg)

$-0.01 (-0.98%)
Prev Close
$1.02
Open
$1.03
Day's High
$1.04
Day's Low
$0.98
Volume
338,687
Avg. Vol
167,355
52-wk High
$6.58
52-wk Low
$0.93

Chart for

About

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive,... (more)

Overall

Beta: --
Market Cap(Mil.): $758.06
Shares Outstanding(Mil.): 107.53
Dividend: --
Yield (%): --

Financials

  AXON.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.09 -- --
ROI: -85.17 8.99 14.48
ROE: -95.04 10.13 15.99

Earnings vs. Estimates